(Q36223607)

12 August 2017

1 reference

title

Advances in the molecular genetics of acute leukemia (English)

1 reference

12 August 2017

1 reference

Joseph M Scandura

1

1 reference

PubMed ID

16091192

12 August 2017

language of work or name

1 reference

1 September 2005

1 reference

12 August 2017

Current Oncology Reports

1 reference

12 August 2017

7

1 reference

12 August 2017

5

1 reference

12 August 2017

323-332

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-005-0058-1

12 August 2017

0 references

cites work

Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-005-0058-1

Down-modulation of the C/EBPalpha transcription factor in core binding factor acute myeloid leukemias

21 January 2018

1 reference

12 December 2020

Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia.

1 reference

12 December 2020

Gene expression profiling of pediatric acute myelogenous leukemia

1 reference

12 December 2020

Detection and interpretation of altered methylation patterns in cancer cells

1 reference

12 December 2020

Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival.

1 reference

12 December 2020

Mutational analysis of the tyrosine kinome in colorectal cancers

1 reference

12 December 2020

Inter-platform comparability of microarrays in acute lymphoblastic leukemia

1 reference

12 December 2020

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia

1 reference

12 December 2020

Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis

1 reference

12 December 2020

Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses

1 reference

12 December 2020

Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias

1 reference

12 December 2020

Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia

1 reference

12 December 2020

CpG island methylator phenotype in cancer

1 reference

12 December 2020

Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study

1 reference

12 December 2020

Minimal residual disease studies in acute leukemia

1 reference

12 December 2020

Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia.

1 reference

12 December 2020

Simple rules underlying gene expression profiles of more than six subtypes of acute lymphoblastic leukemia (ALL) patients.

1 reference

12 December 2020

Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia

1 reference

12 December 2020

Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

1 reference

12 December 2020

Genomic microarrays in the spotlight

1 reference

12 December 2020

C-kit mutations in core binding factor leukemias

1 reference

12 December 2020

Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment

1 reference

12 December 2020

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

1 reference

12 December 2020

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

12 December 2020

Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia

1 reference

12 December 2020

Monitoring PML-RARalpha in acute promyelocytic leukemia

1 reference

12 December 2020

P-glycoprotein 170 expression and function as an adverse independent prognostic factor in childhood acute lymphoblastic leukemia.

1 reference

12 December 2020

DNA microarray analysis of hematopoietic stem cell-like fractions from individuals with the M2 subtype of acute myeloid leukemia

1 reference

12 December 2020

National Institutes of Health. NCI gears up for cancer genome project

1 reference

12 December 2020

CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations

1 reference

12 December 2020

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

1 reference

12 December 2020

Prognostically useful gene-expression profiles in acute myeloid leukemia.

1 reference

12 December 2020

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

1 reference

12 December 2020

Potential mechanisms of resistance to cytarabine in AML patients

1 reference

12 December 2020

Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome

1 reference

12 December 2020

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

1 reference

12 December 2020

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling

1 reference

12 December 2020

Internal tandem duplication mutation of FLT3 blocks myeloid differentiation through suppression of C/EBPα expression

1 reference

12 December 2020

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

1 reference

12 December 2020

Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia

1 reference

12 December 2020

Cytogenetics in acute leukemia

1 reference

12 December 2020

Therapeutic intervention in leukemias that express the activated fms-like tyrosine kinase 3 (FLT3): opportunities and challenges

1 reference

12 December 2020

AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.

1 reference

12 December 2020

Identification of gene expression profiles that segregate patients with childhood leukemia

1 reference

12 December 2020

Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995)

1 reference

12 December 2020

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

1 reference

12 December 2020

Transcription factor fusions in acute leukemia: variations on a theme.

1 reference

12 December 2020

10.1007/S11912-005-0058-1

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16091192